Docebo Announces Participation in Upcoming Investor Conferences in March

Mon, 02 Mar 2026 16:02:00 -0500

TORONTO--(BUSINESS WIRE)-- Docebo Inc. (NASDAQ: DCBO, TSX: DCBO), a leading AI workforce readiness platform that connects skills intelligence, learning execution, and measurable outcomes, announced today that members of its management team will present at the following investor and software industry conferences in March 2026:

29th Annual Scotiabank TMT Conference - March 3rd - Toronto

Morgan Stanley Technology, Media & Telecom Conference - March 5th - San Francisco

2026 Cantor Global Technology & Industrial Growth Conference - March 10th - New York

For more information about these and other events, access the events and presentations page on Docebo’s investor relations website

Docebo Inc. (DCBO) PT Lowered to $36 at Canaccord following Q4 results

Mon, 02 Mar 2026 10:54:01 -0500

Canaccord analyst Robert Young lowered the price target on Docebo Inc. (NASDAQ: DCBO) to $36.00 (from $40.00) while maintaining a Buy rating.

The analyst commented, "Docebo delivered Q4/25 results in line with pre-announced financials and reaffirmed guidance provided on January 31. In line results amid continued risk on SaaS from AI
disruption combined with a US$60M Substantial Issuer Bid (SIB) priced at $20.40 expiring
March 10 dampened any significant movement in the stock, in our view. While growth is
still challenged at 10-11%, we note that normalizing for recent customer losses (AWS and
Dayforce) exposes improved ARR growth of ~14.5% YoY

Docebo Inc. (DCBO) PT Lowered to $36 at Canaccord following Q4 results

Mon, 02 Mar 2026 10:54:01 -0500

Canaccord analyst Robert Young lowered the price target on Docebo Inc. (NASDAQ: DCBO) to $36.00 (from $40.00) while maintaining a Buy rating.

Docebo Inc. (DCBO) PT Lowered to $38 at Craig-Hallum

Mon, 02 Mar 2026 10:02:53 -0500

Craig-Hallum analyst George Sutton lowered the price target on Docebo Inc. (NASDAQ: DCBO) to $38.00 while maintaining a Buy rating.

The analyst commented: maintaining a Buy rating on DCBO, despite a reduction in his price target to $38, arguing that the market has yet to recognize the company’s potential as a primary beneficiary of AI. Sutton asserts that the firm is successfully capturing market share from legacy providers—as evidenced by recent deal wins—and is strategically positioned to capitalize on the AI upskilling trend following the acquisition of 365Talents. By owning both the data and execution layers, the company can effectively integrate

Docebo Inc. (DCBO) PT Lowered to $38 at Craig-Hallum

Mon, 02 Mar 2026 10:02:53 -0500

Craig-Hallum analyst George Sutton lowered the price target on Docebo Inc. (NASDAQ: DCBO) to $38.00 while maintaining a Buy rating.

Docebo Inc. (DCBO) PT Lowered to $26 at Morgan Stanley

Mon, 02 Mar 2026 08:17:11 -0500

Morgan Stanley analyst Josh Baer lowered the price target on Docebo Inc. (NASDAQ: DCBO) to $26.00 (from $28.00) while maintaining a Equalweight rating.

Docebo Inc. (DCBO) PT Lowered to $25 at Scotiabank

Mon, 02 Mar 2026 07:19:12 -0500

Scotiabank analyst Kevin Krishnaratne lowered the price target on Docebo Inc. (NASDAQ: DCBO) to $25.00 (from $32.00) while maintaining a Sector Outperform rating.

Form 6-K Docebo Inc. For: Dec 31

Fri, 27 Feb 2026 06:52:00 -0500

si-local-file:///var/storage/secattach/20260227/26075407.html

Form 6-K Docebo Inc. For: Dec 31

Fri, 27 Feb 2026 06:52:00 -0500

si-local-file:///var/storage/secattach/20260227/26075407.html

Form 40-F Docebo Inc. For: Dec 31

Fri, 27 Feb 2026 06:49:00 -0500

si-local-file:///var/storage/secattach/20260227/26075391.html

Form 40-F Docebo Inc. For: Dec 31

Fri, 27 Feb 2026 06:49:00 -0500

si-local-file:///var/storage/secattach/20260227/26075391.html

Docebo Inc. (DCBO) Tops Q4 EPS by 10c, provides guidance

Fri, 27 Feb 2026 06:01:48 -0500

Docebo Inc. (NASDAQ: DCBO) reported Q4 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $63 million versus the consensus estimate of $62.06 million.

GUIDANCE:

Docebo Inc. sees Q1 2026 revenue of $63.5-63.7 million, versus the consensus of $63.416 million.

Docebo Inc. sees FY2026 revenue of $267.5-269.5 million, versus the consensus of $268.8 million.

For earnings history and earnings-related data on Docebo Inc. (DCBO) click here.